Open access · OA
via Europe PMC
Editorial: Microbiota-immune interactions: a new frontier in cancer treatment optimization.
Frontiers in immunology · 2026
Abstract
This editorial from Frontiers in Immunology 2026 examines the role of microbiota-immune interactions within the context of cancer treatment optimization.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3389/fimmu.2026.1882251
- Canonical
- link ↗
- Fetched
- 2026-07-01 MST
Cite this
APA
S, B., L, M., & S., S. (2026). Editorial: Microbiota-immune interactions: a new frontier in cancer treatment optimization. <em>Frontiers in immunology</em>. https://doi.org/10.3389/fimmu.2026.1882251
Vancouver
S B, L M, S. S. Editorial: Microbiota-immune interactions: a new frontier in cancer treatment optimization. Frontiers in immunology. 2026. doi:10.3389/fimmu.2026.1882251.
BibTeX
@article{blake2026Editor,
title = {Editorial: Microbiota-immune interactions: a new frontier in cancer treatment optimization.},
author = {Blake S and Mortara L and Spada S.},
journal = {Frontiers in immunology},
year = {2026},
doi = {10.3389/fimmu.2026.1882251},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell Metabolism 2024
Open access · OA
The intersection of frailty and metabolism
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2019
Open access · OA
ER-mitochondria interactions: Both strength and weakness within cancer cells
Trends in Genetics 2013
Preprint · OA
Telomerase at the intersection of cancer and aging
Nature reviews. Cancer 2022
Open access · OA
Exploiting senescence for the treatment of cancer
HemaSphere 2026
Open access · OA
Decoding cancer-associated ribosomal protein mutations: A new frontier in cancer and ribosome biology.
Mayo Clinic Proceedings 2008
Open access · OA